Reasons to Be Hopeful
Reasons to Be Hopeful
New findings about Alzheimer’s disease advance the search for more effective treatments.
Alzheimer’s Disease Mucke LabGladstone NOW: The Campaign Join Us on the Journey ✕
76 - 90 of 104 Results Clear All
New findings about Alzheimer’s disease advance the search for more effective treatments.
Alzheimer’s Disease Mucke LabResearchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.
Mucke Lab Alzheimer’s DiseaseBy repurposing a prescription drug used to treat rheumatoid arthritis, researchers at the Gladstone Institutes successfully reversed tau-related symptoms in an animal model of dementia.
Alzheimer’s Disease Gan LabMembers of the Gladstone community raised funds and participated in the 2015 Annual Walk to End Alzheimer’s.
Alzheimer’s DiseaseHear Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease, discuss progress towards Alzheimer’s cures during his recent City Arts & Lectures appearance.
Mucke Lab Alzheimer’s DiseaseThe initiative will fast-track new approaches to treat Alzheimer’s disease.
Alzheimer’s DiseaseLi Gan, PhD, has been selected to present the Inge Grundke-Iqbal Lecture for Alzheimer’s Research at the Alzheimer’s Association International Conference (AAIC) in Washington, D.C. in July.
Alzheimer’s DiseaseRaising levels of the life-extending protein klotho can protect against learning and memory deficits in a mouse model of Alzheimer’s disease, despite the accumulation of Alzheimer-related toxins in the brain.
Mucke Lab Aging Alzheimer’s DiseaseLow levels of the naturally occurring protein progranulin exacerbate cellular and cognitive dysfunction, while raising levels can prevent abnormalities in an Alzheimer model.
Alzheimer’s DiseaseSAN FRANCISCO, CA—A new study from the Gladstone Institutes has revealed a way to alleviate the learning and memory deficits caused by apoE4, the most important genetic risk factor for Alzheimer’s disease, improving cognition to normal levels in aged mice.
Huang Lab Alzheimer’s DiseaseA joint Gladstone-UCSF study reveals a gene linked to longevity also improves learning and memory. This discovery opens a new path for treating Alzheimer’s and other aging-related diseases.
Mucke Lab Aging Alzheimer’s DiseaseSAN FRANCISCO, CA—Alzheimer’s disease is one of the greatest challenges facing modern medicine, but there is new hope in the fight against this deadly disease.
Huang Lab Mahley Lab Neurological Disease Alzheimer’s DiseaseSAN FRANCISCO, CA—Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, next week will receive the ARCS Foundation’s 2013 Pacesetter Award for his lifelong dedication to overcoming Alzheimer’s disease—and for mentoring students to take a similar approach.
Mucke Lab Neurological Disease Alzheimer’s DiseaseSAN FRANCISCO, CA—There is no easy way to study diseases of the brain. Extracting brain cells, or neurons, from a living patient is difficult and risky, while examining a patient’s brain post-mortem usually only reveals the disease’s final stages.
Huang Lab Alzheimer’s Disease Stem Cells/iPSCsSAN FRANCISCO, CA—Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, today received the MetLife Foundation’s 2013 Award for Medical Research in Alzheimer’s Disease at a scientific briefing and awards ceremony in New York.
Alzheimer’s Disease Mucke Lab